Need professional-grade analysis? Visit stockanalysis.com
$2.79B
4.82
10
4.52%
BB Biotech AG (BBZA) trades on XETRA (Frankfurt) in EUR. The company is classified in the Healthcare sector under the Biotechnology industry. The stock currently trades at EUR49.85, down 1.29% from the previous close.
Over the past year, BBZA has traded between a low of EUR30.05 and a high of EUR53.10. The stock has gained 65.9% over this period. It is currently 6.1% below its 52-week high.
BB Biotech AG has a market capitalization of $2.79B, with a price-to-earnings ratio of 4.82 and a dividend yield of 4.52%.
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.
Side-by-side comparison against top Healthcare peers.